RxLink
RxLink is an AI-driven medication affordability platform that helps health systems, digital health companies, and patients identify the lowest-cost prescription options by aggregating insurance, discount cards, manufacturer offers, and 340B pricing into its MedMap™ recommendation engine delivered via SMS.
- Company typePrivate
- Founded2023
- HeadquartersRaleigh, United States
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What RxLink does
RxLink is an AI-driven medication affordability platform that helps health systems, digital health companies, and patients identify the lowest-cost option for a prescribed therapy. Its core product is MedMap™, a personalized recommendation engine that aggregates insurance copays, third-party discount cards, pharmaceutical manufacturer offers, pharmacy-specific cash prices, and 340B pricing into a single per-patient view, then delivers that view to patients via SMS at the point of prescription and through a web portal. The platform integrates with e-prescribing workflows and electronic health record systems so that savings recommendations appear without adding work to care teams, and it offers programmatic API access to its affordability data for partner integrations.
RxLink's customer base is anchored in U.S. health systems, with secondary segments in digital health platforms, employers, and health plans/payers. The company's partnerships include Mark Cuban Cost Plus Drug Company (whose transparent pricing is integrated into MedMap) and ConnectiveRx (whose manufacturer-sponsored patient support programs extend MedMap's affordability surface). Health systems use RxLink to capture pharmacy revenue leakage, drive prescription transfer into in-house 340B pharmacies, and improve patient adherence; one regional health system partner delivered over $1M in patient savings to 12,000 patients within six months, and Gulf Coast Regional Health System patients saved $480,000 in the first quarter of a deployment.
RxLink's business model is a no-fee distribution to health systems and patients, with revenue generated through transaction economics tied to prescription volume directed to partner health system pharmacies, particularly 340B programs. The company was founded as a privately held Delaware corporation; it received Triangle Tweener Fund backing in April 2024 and was acquired by DoseSpot, a PSG Equity-backed e-prescribing platform, in December 2024. DoseSpot subsequently merged with Arrive Health in 2026 to form Interra Health, with Bain Capital Tech Opportunities investing alongside PSG. Headquartered in Chapel Hill, NC, RxLink operated with a small (1–10) team pre-acquisition.
RxLink firmographics
Firmographics- Name
- RxLink
- Legal name
- RxLink Inc
- Website
- https://rxlink.com
- Company type
- Private
- Founded year
- 2023
- Operating status
- Acquired
- Headcount range
- 1–10 employees
- Short description
- RxLink is an AI-driven medication affordability platform that helps health systems, digital health companies, and patients identify the lowest-cost prescription options by aggregating insurance, discount cards, manufacturer offers, and 340B pricing into its MedMap™ recommendation engine delivered via SMS.
- Ownership category
- akta.pro rank
RxLink industry classification
Industry- Product category
- Healthcare Price Transparency Software
- NAICS
- Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds (524292)
- akta.pro primary industry
- Medication Pricing, Copay Assistance & Patient Financial Support Tools (HLACAKAN)
- akta.pro secondary industry
- PBM Technology Platforms (ePA/eRx/Real-Time Benefit Tools) (HLAEAKAL)
Keywords
Where RxLink is headquartered
LocationHeadquarters
- HQ city
- Raleigh
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
RxLink business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
Revenue model
- Health System Partnership Model: RxLink provides its medication affordability platform to health systems at no cost. The company generates value by driving prescription volume to health system pharmacies (particularly 340B programs), improving patient adherence, and enabling pharmacy revenue growth. The platform is described as being delivered at no cost to partners or patients.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
RxLink product offering
Product offeringCore offering
RxLink operates an AI-driven medication affordability platform that automatically identifies the lowest-cost prescription therapy options for each patient by comparing insurance copays, manufacturer copay offers, third-party discount cards, and cash pharmacy prices. Its proprietary MedMap™ product delivers personalized savings recommendations via SMS and a web interface, integrates with EHR and e-prescribing platforms, and supports health system partners with 340B pharmacy revenue growth and prescription transfer workflows.
Product overview
RxLink is an AI-driven medication affordability platform designed to help patients save on prescription costs. The core product is MedMap, a proprietary recommendation engine that automatically identifies the best savings options for each patient by comparing insurance copays, discount cards, manufacturer offers, and pharmacy cash prices. The platform integrates with health systems, EHRs, and e-prescribing platforms to deliver savings information via SMS and web portal at the point of care. RxLink also offers a 340B Pharmacy Growth Program that helps health systems capture prescription revenue and drive patients to in-house pharmacies.
Differentiator
Problem solved
Functional benefit
Brands
- MedMap™: Proprietary platform that delivers personalized medication savings information to patients, displaying prescribed medications, out-of-pocket costs, ways to save, and options to transfer prescriptions to health system pharmacies.
Products and services
- MedMap™ Proprietary AI-driven recommendation engine that automatically analyzes a patient's insurance, discount cards, manufacturer offers, and pharmacy pricing to deliver personalized prescription savings recommendations via SMS and a web interface. Built for health systems, digital health companies, and the patients they serve.
- 340B Pharmacy Growth Program Turnkey solution that helps health systems shift 340B-eligible prescriptions to in-house pharmacies, educate patients on cost savings at hospital pharmacies, drive prescription volume, and capture net new patient margin. Targeted at hospital pharmacy leaders and 340B program managers.
- SMS Patient Messaging Automated SMS service that delivers prescription savings information directly to patients immediately after a healthcare encounter, including personalized MedMap links and instructions for obtaining lowest-cost medications. Used by health system partners to improve medication adherence.
- RxLink API
Quantifiable outcome
- Saves patients an average of over $100 per month on prescriptions
- +3 more outcomes
Companies that use RxLink
Customer profileNamed customers1 record
Segments5 records
Ideal customer profiles3 records
RxLink technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
AI capability2 records
Feature1 record
RxLink partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core.
- DoseSpotcoreDoseSpot acquired RxLink in December 2024 as part of PSG's strategy to build a broader clinical workflow platform. The acquisition was part of DoseSpot's three acquisitions (TreatRx, pVerify, and RxLink) to expand capabilities in insurance eligibility verification and medication affordability. The companies merged with Arrive Health in 2026 to form Interra Health.
- ConnectiveRxcoreStrategic partnership between RxLink and ConnectiveRx to further expand patient medication affordability. The collaboration enables healthcare providers to help patients reduce out-of-pocket prescription costs by providing access to available savings options from pharmaceutical manufacturers via text message. RxLink's MedMap platform is combined with ConnectiveRx's portfolio of patient support programs.
- Mark Cuban Cost Plus Drug CompanycorePartnership to bring pharmacy cost transparency to patients of leading health systems. RxLink's MedMap now includes Cost Plus Drugs pricing, automatically accounting for patients' insurance, third-party discount cards, and manufacturer offers to provide lowest-cost recommendations. Over $162,000 in patient savings were identified in the first 3 months.
- Arrive HealthcoreDoseSpot merged with Arrive Health in 2026 to form Interra Health, creating a comprehensive clinical workflow and medication affordability platform.
Scale indicators8 records
Recent moves6 records
Expansion highlights7 records
RxLink competitors and assessment
Company assessmentBroad incumbents
- Optum Rx: Optum Rx is one of the largest US PBMs and a subsidiary of UnitedHealth Group, increasingly bundling affordability, transparency, and home-delivery tools with its PBM services. It is a broad incumbent whose internal tools compete with RxLink for the same provider and patient workflows.
- CoverMyMeds: CoverMyMeds (a McKesson business) is a leading electronic prior authorization and medication access platform that also surfaces affordability options within prescribing workflows. Comparable to RxLink in its provider-embedded affordability focus, but at much larger scale and as part of McKesson's broader pharma services portfolio.
- Surescripts: Surescripts operates the dominant US health information network for e-prescribing and now provides Real-Time Prescription Benefit (RTPB) tools used inside EHRs. It is a broad incumbent in the same workflow as RxLink, with the network and incumbency advantages that RxLink integrates against rather than competes head-on with.
Direct peers
- RxSaver: RxSaver (operated by RetailMeNot/Emergence Capital-backed) is a consumer prescription discount and price comparison platform. It competes with RxLink on aggregating pharmacy pricing and discount card options, though primarily via consumer engagement rather than provider integration.
- Arrive Health: Arrive Health provides real-time prescription benefit and pricing transparency at the point of prescribing, integrated with EHRs and e-prescribing workflows. It is the closest direct comparable to RxLink's provider-embedded affordability layer and is now part of the same Interra Health entity following the 2026 DoseSpot merger.
- SingleCare: SingleCare is a prescription savings card and telehealth-adjacent platform that negotiates discounts with pharmacies and offers them to consumers. Comparable to RxLink in delivering lower-cost prescription options to patients and pursuing employer/payer channel partnerships.
- GoodRx: GoodRx is a leading consumer-facing prescription savings platform that aggregates discount card pricing, manufacturer coupons, and pharmacy pricing to lower patient out-of-pocket costs. It directly overlaps RxLink's core savings-comparison and affordability functionality, though GoodRx is consumer-pull whereas RxLink is provider-push.
Emerging players
- Waltz Health: Waltz Health is an AI-driven prescription search and pricing platform that helps payers, providers, and consumers find lower-cost medication options. It is comparable to RxLink in using technology to optimize medication affordability and routing, positioning itself as a competitor in the same emerging AI-pricing space.
- Capital Rx: Capital Rx is a technology-first PBM building a transparent, claims-engine-driven pharmacy benefit platform with built-in member-facing pricing tools. It overlaps with RxLink's affordability and transparency thesis at the payer/employer layer and represents a competing model for delivering real-time Rx pricing to patients.
- Sempre Health: Sempre Health uses dynamic, personalized pricing incentives (including copay reductions) to drive medication adherence for chronic-disease patients, working with health plans and providers. Comparable to RxLink in addressing affordability to improve adherence, but with a stronger behaviorally-driven incentive model.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
RxLink compliance and trust
Trust signalCompliance1 record
RxLink financial estimates
Financial estimateRevenue estimate
Valuation estimate
RxLink leadership team
Management profileNumber of profiles
Profiles3 records
RxLink funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
RxLink M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about RxLink
What does RxLink do?
RxLink operates an AI-driven medication affordability platform that automatically identifies the lowest-cost prescription therapy options for each patient by comparing insurance copays, manufacturer copay offers, third-party discount cards, and cash pharmacy prices. Its proprietary MedMap™ product delivers personalized savings recommendations via SMS and a web interface, integrates with EHR and e-prescribing platforms, and supports health system partners with 340B pharmacy revenue growth and prescription transfer workflows.
Is RxLink a public or private company?
RxLink is a private company. It is classified as private equity controlled and is currently acquired.
When was RxLink founded?
RxLink was founded in 2023. It employs 1 to 10 people.
Where is RxLink based?
RxLink is headquartered in Raleigh, United States, in the North America region.
How does RxLink make money?
One revenue line is on record: health System Partnership Model.
Who are RxLink's main competitors?
Broad incumbents on record are Optum Rx, CoverMyMeds and Surescripts. Direct peers are RxSaver, Arrive Health, SingleCare and GoodRx. Emerging players are Waltz Health, Capital Rx and Sempre Health.
Does RxLink have an API?
Yes. RxLink provides API access to its medication affordability data and MedMap platform for providers, patients, and partners. The API enables delivery of personalized prescription savings information, pricing comparisons, and discount program matching. Source: About Us page states 'RxLink surfaces a personalized Med Map™ for every patient, and provides easy access to the data through an API for providers, patients, and our partners.'
What industry is RxLink in?
RxLink's product category is Healthcare Price Transparency Software. Its primary akta.pro industry code is HLACAKAN, Medication Pricing, Copay Assistance & Patient Financial Support Tools, with a secondary code of HLAEAKAL, PBM Technology Platforms (ePA/eRx/Real-Time Benefit Tools). Its NAICS code is 524292.